Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60637


Purpose:

The purpose of this study is to determine maximum tumor shrinkage, time to progression, survival, drug concentration, and degree of skin toxicity.


Criteria:

Inclusion Criteria: - Histologically or cytologically confirmed metastatic clear cell renal cell cancer; - At least one lesion that can be accurately measured in at least one dimension; - Patients must not have been treated with prior anti-timor kinase inhibitors or VEGF pathway inhibitors; - Age 18 and older; - ECOG performance status 0-2; - Blood pressure higher than 140/90 on 2 separate occasions not more than 6 weeks prior to enrollment and not less than 24 hours apart; - Normal organ function: total bilirubin less than upper limit of normal, AST less than 2.5 X upper limit of normal, creatinine less than 2.8 mg/dl; - Women of child-bearing potential and men must agree to use adequate contraception prior to study entry and for the duration of study participation; - Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: - Chemotherapy or radiotherapy within 4 weeks prior to entering the study; - Any other investigational agents; - Known brain metastases; - Uncontrolled intercurrent illness including ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements; - Pregnancy.


NCT ID:

NCT00606866


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60637
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.